Month: <span>July 2018</span>

Home / 2018 / July
Post

Metformin reverses established lung fibrosisc

Researchers at the University of Alabama at Birmingham have shown—for the first time—that established lung fibrosis can be reversed using a drug treatment that targets cell metabolism. Jaroslaw Zmijewski and Victor Thannickal. Credit: UAB This novel finding, reported in the journal Nature Medicine, is important because, despite significant advances to reveal the pathological mechanisms of persistent fibrosis,...

Post

The World’s First Wireless, App-Based Ultrasound: Interview with Dr. Ryu, CEO of Healcerion

Healcerion, based in South Korea, was the first company to receive FDA clearance for a wireless, app-based ultrasound system back in 2015. The groundbreaking work done by South Korean engineers and scientists laid the foundation for the development of an ultrasound transducer that works with most smartphones or tablets. Since introducing the SONON 300C convex transducer,...

Post

Patients with type 1 diabetes saw blood sugars improve with liraglutide

July 2, 2018, by Ellen Goldbaum, University at Buffalo Researchers from the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo have found that adding liraglutide to insulin treatment for patients with type 1 diabetes results not only in better blood sugar control but simultaneous improvements in blood pressure, body weight and the...

Post

Mindfulness is key to tinnitus relief

A leading UK study has found that a new mindfulness-based approach to tinnitus could transform the treatment of the condition. The BTA estimates tinnitus affects approximately six million people in the UK. Credit: University of Bath Published in the journals Ear and Hearing and Psychotherapy and Psychosomatics, the research, led by Dr. Liz Marks from...

Post

Better connectivity of brain regions with training

Researchers at the Leibniz-Institutes für Wissensmedien (IWM) and of the Graduate School and Research Network LEAD at the University of Tübingen now found out: Short and intensive arithmetic training strengthens the neuronal connections between brain regions in adults. This neuronal plasticity through numerical learning was already detectable after only five training sessions. Results of the...

Post

Predicting bad side effects

Screening a tiny section of DNA could help East Asian patients avoid severe reactions to some medications TOHOKU UNIVERSITY Researchers from Japan’s Tohoku University and colleagues have found that a simple DNA test can predict if East Asian patients are likely to have bad reactions to thiopurine medications. IMAGE: EXPERIMENTING WITH THE DNA KIT AT THE...

Post

Discovery of new biomarker could provide personalized treatment options for bladder cancer

Mount Sinai researchers use data science and genomics to help determine best treatment options for specific bladder cancers THE MOUNT SINAI HOSPITAL / MOUNT SINAI SCHOOL OF MEDICINE A potential new target for treatment has been identified in an aggressive form of bladder cancer, Mount Sinai researchers report in a recent study. Bladder cancers are...

Post

Parkinson’s may soon be treated with blood pressure drug

Isradipine, an antihypertensive drug, is emerging as a potential new treatment for Parkinson’s disease due to promising results of in vitro tests. Until now, it was unclear whether administering the drug in vivo would yield the same benefits — new research shows that it does. Isradipine is a calcium-channel inhibitor used to treat hypertension. Previous studies have...

Post

FDA OKs first drug made to reduce excessive sweating

June 29, 2018 by Linda A. Johnson The U.S. Food and Drug Administration has approved the first drug developed specifically to reduce excessive sweating, a common condition that can cause anxiety. Dermira Inc. said Friday its Qbrexza (cue-BREX’-zah) was approved for excessive underarm sweating. The drug is inside a cloth wiped over the skin daily...